|
1
|
Freedman ND, Ahn J, Hou L, et al:
Polymorphisms in estrogen- and androgen-metabolizing genes and the
risk of gastric cancer. Carcinogenesis. 30:71–77. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xu CY, Guo JL, Jiang ZN, et al: Prognostic
role of estrogen receptor alpha and estrogen receptor beta in
gastric cancer. Ann Surg Oncol. 17:2503–2509. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang Z, Zhang X, Shen P, et al:
Identification, cloning, and expression of human estrogen
receptor-alpha36, a novel variant of human estrogen
receptor-alpha66. Biochem Biophys Res Commun. 336:1023–1027. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shi L, Dong B, Li Z, et al: Expression of
ER-{alpha}36, a novel variant of estrogen receptor {alpha}, and
resistance to tamoxifen treatment in breast cancer. J Clin Oncol.
20:3423–3429. 2009.
|
|
5
|
Lee LM, Cao J, Deng H, et al: ER-alpha36,
a novel variant of ER-alpha, is expressed in ER-positive and
-negative human breast carcinomas. Anticancer Res. 28:479–483.
2008.PubMed/NCBI
|
|
6
|
Jiang H, Teng R, Wang Q, et al:
Transcriptional analysis of estrogen receptor alpha variant mRNAs
in colorectal cancers and their matched normal colorectal tissues.
J Steroid Biochem Mol Biol. 112:20–24. 2008. View Article : Google Scholar
|
|
7
|
Lin SL, Yan LY, Liang XW, et al: A novel
variant of ER-alpha, ER-alpha36 mediates testosterone-stimulated
ERK and Akt activation in endometrial cancer Hec1A cells. Reprod
Biol Endocrinol. 24:1022009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang Z, Zhang X, Shen P, et al: A variant
of estrogen receptor-{alpha}, hER-{alpha}36: transduction of
estrogen- and antiestrogen-dependent membrane-initiated mitogenic
signaling. Proc Natl Acad Sci USA. 103:9063–9068. 2006.
|
|
9
|
Sobin LH and Wittekind C: UICC: TNM
Classification of Malignant Tumours. 5. London: Wiley; 1997
|
|
10
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T). Method Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang HP, Teng RY, Wang Q, et al: Estrogen
receptor alpha variant ERalpha46 mediates growth inhibition and
apoptosis of human HT-29 colon adenocarcinoma cells in the presence
of 17beta-oestradiol. Chin Med J (Engl). 121:1025–1031. 2008.
|
|
13
|
Chandanos E, Rubio CA, Lindblad M, et al:
Endogenous estrogen exposure in relation to distribution of
histological type and estrogen receptors in gastric adenocarcinoma.
Gastric Cancer. 11:168–174. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kameda C, Nakamura M, Tanaka H, et al:
Oestrogen receptor-alpha contributes to the regulation of the
hedgehog signalling pathway in ERalpha-positive gastric cancer. Br
J Cancer. 16:738–747. 2010. View Article : Google Scholar
|
|
15
|
Zhao XH, Gu SZ, Liu SX, et al: Expression
of estrogen receptor and estrogen receptor messenger RNA in gastric
carcinoma tissues. World J Gastroenterol. 9:665–669.
2003.PubMed/NCBI
|
|
16
|
Wang M, Pan JY, Song GR, et al: Altered
expression of estrogen receptor alpha and beta in advanced gastric
adenocarcinoma: correlation with prothymosin alpha and
clinicopathological parameters. Eur J Surg Oncol. 33:195–201. 2007.
View Article : Google Scholar
|
|
17
|
Oshima CT, Wonraht DR, Catarino RM, Mattos
D and Forones NM: Estrogen and progesterone receptors in gastric
and colorectal cancer. Hepatogastroenterology. 46:3155–3158.
1999.PubMed/NCBI
|
|
18
|
Raso MG, Behrens C, Herynk MH, et al:
Immunohistochemical expression of estrogen and progesterone
receptors identifies a subset of NSCLCs and correlates with EGFR
mutation. Clin Cancer Res. 15:5359–5368. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nüssler NC, Reinbacher K, Shanny N, et al:
Sex-specific differences in the expression levels of estrogen
receptor subtypes in colorectal cancer. Gend Med. 5:209–217.
2008.PubMed/NCBI
|
|
20
|
Chandanos E, Lindblad M, Rubio CA, et al:
Tamoxifen exposure in relation to gastric adenocarcinoma
development. Eur J Cancer. 44:1007–1014. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Izawa M, Inoue M, Osaki M, et al:
Cytochrome P450 aromatase gene (CYP19) expression in gastric
cancer. Gastric Cancer. 11:103–110. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Harrison JD, Morris DL, Ellis IO, Jones JA
and Jackson I: The effect of tamoxifen and estrogen receptor status
on survival in gastric carcinoma. Cancer. 64:1007–1010. 1989.
View Article : Google Scholar : PubMed/NCBI
|
